MX2007011665A - Terapeutico para influenza. - Google Patents
Terapeutico para influenza.Info
- Publication number
- MX2007011665A MX2007011665A MX2007011665A MX2007011665A MX2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A
- Authority
- MX
- Mexico
- Prior art keywords
- rnai
- influenza
- inducing
- influenza virus
- provides
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title 1
- 108091030071 RNAI Proteins 0.000 abstract 6
- 230000009368 gene silencing by RNA Effects 0.000 abstract 6
- 230000001939 inductive effect Effects 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 241000712461 unidentified influenza virus Species 0.000 abstract 3
- 241000271566 Aves Species 0.000 abstract 1
- 241001500351 Influenzavirus A Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091027967 Small hairpin RNA Proteins 0.000 abstract 1
- 108020004459 Small interfering RNA Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 229940124447 delivery agent Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66458005P | 2005-03-22 | 2005-03-22 | |
| US11/102,097 US20060160759A1 (en) | 2002-09-28 | 2005-04-08 | Influenza therapeutic |
| PCT/US2006/010491 WO2006102461A2 (en) | 2005-03-22 | 2006-03-22 | Influenza therapeutic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007011665A true MX2007011665A (es) | 2007-11-14 |
Family
ID=39406020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007011665A MX2007011665A (es) | 2005-03-22 | 2006-03-22 | Terapeutico para influenza. |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2008533990A (https=) |
| CN (1) | CN101180395A (https=) |
| IL (1) | IL186057A0 (https=) |
| MX (1) | MX2007011665A (https=) |
| NO (1) | NO20074929L (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103966212A (zh) * | 2013-02-06 | 2014-08-06 | 霍晋 | A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用 |
| CN103966214A (zh) * | 2013-02-06 | 2014-08-06 | 霍晋 | A型流感病毒PB基因有干扰作用的siRNA序列的设计及应用 |
| CN103966213A (zh) * | 2013-02-06 | 2014-08-06 | 霍晋 | A型流感病毒M基因有干扰作用的siRNA序列的设计和干扰作用的鉴定 |
| MX2015017312A (es) * | 2013-06-17 | 2017-04-10 | Broad Inst Inc | Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas. |
| US20160177296A1 (en) * | 2014-01-23 | 2016-06-23 | Colorado State University Research Foundation | E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS |
| CN106381296A (zh) * | 2015-11-19 | 2017-02-08 | 中国农业科学院哈尔滨兽医研究所 | 表达多基因抗流感转基因动物的构建方法 |
| CN106947763B (zh) * | 2017-03-20 | 2019-11-12 | 中国医学科学院医药生物技术研究所 | 可雾化吸入的抗流感病毒感染的siRNA及其应用 |
| CN118079011A (zh) * | 2019-02-01 | 2024-05-28 | 利兰斯坦福初级大学董事会 | 用于将核酸递送至肺部的分解性细胞穿透复合物 |
| US12589161B2 (en) * | 2019-07-10 | 2026-03-31 | The University Of Hong Kong | PEGylated synthetic KL4 peptide, compositions and methods thereof |
-
2006
- 2006-03-22 CN CNA2006800177344A patent/CN101180395A/zh active Pending
- 2006-03-22 MX MX2007011665A patent/MX2007011665A/es not_active Application Discontinuation
- 2006-03-22 JP JP2008503156A patent/JP2008533990A/ja active Pending
-
2007
- 2007-09-19 IL IL186057A patent/IL186057A0/en unknown
- 2007-09-28 NO NO20074929A patent/NO20074929L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101180395A (zh) | 2008-05-14 |
| NO20074929L (no) | 2007-12-18 |
| JP2008533990A (ja) | 2008-08-28 |
| IL186057A0 (en) | 2008-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006102461A3 (en) | Influenza therapeutic | |
| Ji et al. | NS1: a key protein in the “game” between influenza A virus and host in innate immunity | |
| Zhang et al. | Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA | |
| NO20074929L (no) | Influensa terapeutisk middel | |
| MX385869B (es) | Agentes de iarn modificados. | |
| MX2024005653A (es) | Agentes de acido ribonucleico (arn) de cadena doble modificados. | |
| JP2010505897A (ja) | インフルエンザターゲット | |
| WO2015106128A3 (en) | Rnai agents modified at the 4'-c-position | |
| JP2019508045A (ja) | がんを処置するための組み合わせベクターおよび方法 | |
| PH12021551135A1 (en) | Rna encoding a protein | |
| JP2024500036A (ja) | 抱合体 | |
| Ouyang et al. | gga-miR-2127 downregulates the translation of chicken p53 and attenuates chp53-mediated innate immune response against IBDV infection | |
| BR112019009953A2 (pt) | substâncias direcionadas a vários órgãos ou tecidos selecionados | |
| US20200345756A1 (en) | Compositions and methods for treating age-related macular degeneration and geographic atrophy | |
| WO2010002851A1 (en) | Silencing and rig-1 activation by dual function oligonucleotides | |
| Stoppani et al. | Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin | |
| KR101638156B1 (ko) | C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물 | |
| RU2016131028A (ru) | Композиции, содержащие асимметричную интерферирующую рнк, которые подвергают сайленсингу k-ras, и способы их применения | |
| Liu et al. | ASF1a enhances antiviral immune response by associating with CBP to mediate acetylation of H3K56 at the Ifnb promoter | |
| Yuan et al. | A RNAi-based strategy to suppress Micropterus salmoides rhabdovirus in GCO cells and largemouth bass by silencing envelope glycoprotein | |
| Talari et al. | MicroRNA-712 restrains macrophage pro-inflammatory responses by targeting LRRK2 leading to restoration of insulin stimulated glucose uptake by myoblasts | |
| JP4054844B2 (ja) | 副作用のないＲＮＡｉ医薬 | |
| JP7639035B2 (ja) | 骨量減少または筋機能低下に関連する病的状態を治療する際に使用するためのマイクロｒｎａ１９ａ／１９ｂ | |
| KR101783444B1 (ko) | miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법 | |
| US9295709B2 (en) | Pharmaceutical composition comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-202-5P inhibitor for inhibiting cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |